MLMaria T. Luz

Maria T. Luz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria T. Luz has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Ana Vázquez

    Centro Nacional de Microbiología, Instituto de Salud Carlos III, CNM-ISCIII, Madrid, Spain

    1 shared publication
  • Fernando de Ory

    Servicio de Microbiología Diagnóstica, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, España

    1 shared publication
  • Fátima Amaro

    INSA, Centre for Vectors and Infectious Diseases Research, National Institute of Health Doctor Ricardo Jorge, Avenida da Liberdade, Águas de Moura, Portugal

    1 shared publication
  • Jesús De La Fuente

    Laboratorio de Serología y Arbovirus, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Majadahonda, Spain

    1 shared publication
  • Líbia Zé-Zé

    INSA, Centre for Vectors and Infectious Diseases Research, National Institute of Health Doctor Ricardo Jorge, Avenida da Liberdade, Águas de Moura, Portugal

    1 shared publication
  • Maria João Alves

    Department of Infectious Diseases, Centre for Vectors and Infectious Diseases Research (CEVDI), National Institute of Health Doutor Ricardo Jorge (INSA), Águas de Moura, Portugal

    1 shared publication

Latest Publications

  • Open Access

    The Application and Interpretation of IgG Avidity and IgA ELISA Tests to Characterize Zika Virus Infections

    by Fátima Amaro, María P. Sánchez-Seco, Ana Vázquez, Maria J. Alves, Líbia Zé-Zé, Maria T. Luz, Teodora Minguito, Jesús De La Fuente, Fernando De Ory

    In the absence of viremia, the diagnostics of Zika virus (ZIKV) infections must rely on serological techniques. In order to improve the serological diagnosis of ZIKV, ZIKV-IgA and ZIKV-IgG avidity assays were evaluated. Forty patients returning from ZIKV endemic areas, with confirmed or suspected ZIKV infections were studied. Samples were classified as early acute, acute and late acute according to the number of days post illness onset. Low avidity IgG was only detected at acute and late acute stages and IgA mostly at the early acute and acute stages. The date of sampling provides useful information and can help to choose the best technique to use at a determined moment in time and to interpret low avidity IgG and IgA results, improving the serological diagnosis of ZIKV.